Literature DB >> 19788501

TNF receptors differentially signal and are differentially expressed and regulated in the human heart.

R S Al-Lamki1, A P Brookes, J Wang, M J Reid, J Parameshwar, M J Goddard, G Tellides, T Wan, W Min, J S Pober, J R Bradley.   

Abstract

Tumor necrosis factor (TNF) utilizes two receptors, TNFR1 and 2, to initiate target cell responses. We assessed expression of TNF, TNFRs and downstream kinases in cardiac allografts, and compared TNF responses in heart organ cultures from wild-type ((WT)C57BL/6), TNFR1-knockout ((KO)), TNFR2(KO), TNFR1/2(KO) mice. In nonrejecting human heart TNFR1 was strongly expressed coincidentally with inactive apoptosis signal-regulating kinase-1 (ASK1) in cardiomyocytes (CM) and vascular endothelial cells (VEC). TNFR2 was expressed only in VEC. Low levels of TNF localized to microvessels. Rejecting cardiac allografts showed increased TNF in microvessels, diminished TNFR1, activation of ASK1, upregulated TNFR2 co-expressed with activated endothelial/epithelial tyrosine kinase (Etk), increased apoptosis and cell cycle entry in CM. Neither TNFR was expressed significantly by cardiac fibroblasts. In (WT)C57BL/6 myocardium, TNF activated both ASK1 and Etk, and increased both apoptosis and cell cycle entry. TNF-treated TNFR1(KO) myocardium showed little ASK1 activation and apoptosis but increased Etk activation and cell cycle entry, while TNFR2(KO) myocardium showed little Etk activation and cell cycle entry but increased ASK1 activation and apoptosis. These observations demonstrate independent regulation and differential functions of TNFRs in myocardium, consistent with TNFR1-mediated cell death and TNFR2-mediated repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788501      PMCID: PMC3517885          DOI: 10.1111/j.1600-6143.2009.02831.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  47 in total

1.  Inhibition of tumor necrosis factor-alpha does not prevent cardiac allograft arteriosclerosis in the rat.

Authors:  V P Pulkkinen; R K Sihvola; P K Koskinen; K B Lemström
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  TNF-alpha in acute cardiac transplant rejection.

Authors:  M Azzawi; P S Hasleton; I V Hutchinson
Journal:  Cytokines Cell Mol Ther       Date:  1999-03

Review 3.  Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

Authors:  W J Sandborn; S B Hanauer
Journal:  Inflamm Bowel Dis       Date:  1999-05       Impact factor: 5.325

4.  Intragraft cytokine expression in heart transplants with mild or no histological rejection.

Authors:  C M Alvarez; D Fernández; M Builes; J Zabaleta; L M Restrepo; A Villegas; L F García
Journal:  Clin Transplant       Date:  2001-08       Impact factor: 2.863

5.  Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair.

Authors:  M Kanoh; G Takemura; J Misao; Y Hayakawa; T Aoyama; K Nishigaki; T Noda; T Fujiwara; K Fukuda; S Minatoguchi; H Fujiwara
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

Review 6.  Tumor necrosis factor-alpha converting enzyme.

Authors:  Roy A Black
Journal:  Int J Biochem Cell Biol       Date:  2002-01       Impact factor: 5.085

7.  Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium.

Authors:  M W Irwin; S Mak; D L Mann; R Qu; J M Penninger; A Yan; F Dawood; W H Wen; Z Shou; P Liu
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

8.  Evidence that human cardiac myocytes divide after myocardial infarction.

Authors:  A P Beltrami; K Urbanek; J Kajstura; S M Yan; N Finato; R Bussani; B Nadal-Ginard; F Silvestri; A Leri; C A Beltrami; P Anversa
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

9.  Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis.

Authors:  Shi Pan; Ping An; Rong Zhang; Xiangrong He; Guoyong Yin; Wang Min
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

10.  Signaling network of the Btk family kinases.

Authors:  Y Qiu; H J Kung
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

View more
  22 in total

Review 1.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

2.  Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells.

Authors:  Danielle D Kish; Nina Volokh; William M Baldwin; Robert L Fairchild
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

3.  Preferential TNFα signaling via TNFR2 regulates epithelial injury and duct obstruction in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Tatsuki Mizuochi; Reena Mourya; Sridevi Gutta; Li Yang; Zhenhua Luo; Jorge A Bezerra
Journal:  JCI Insight       Date:  2017-03-09

4.  Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice.

Authors:  Szabolcs Bertok; Michael R Wilson; Anthony D Dorr; Justina O Dokpesi; Kieran P O'Dea; Nandor Marczin; Masao Takata
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-04       Impact factor: 5.464

5.  TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic-like fate.

Authors:  Tariq Hamid; Yuanyuan Xu; Mohamed Ameen Ismahil; Qianhong Li; Steven P Jones; Aruni Bhatnagar; Roberto Bolli; Sumanth D Prabhu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-02       Impact factor: 4.733

6.  In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-α-induced apoptosis and proliferation by MAPKs.

Authors:  Ken S Lau; Alwin M Juchheim; Kimberly R Cavaliere; Sarah R Philips; Douglas A Lauffenburger; Kevin M Haigis
Journal:  Sci Signal       Date:  2011-03-22       Impact factor: 8.192

7.  TNFR2 expression on non-bone marrow-derived cells is crucial for lipopolysaccharide-induced septic shock and downregulation of soluble TNFR2 level in serum.

Authors:  Shubai Liu; Lijie Rong; Jingjing Deng; Xiaopu Zhao; Xiaoman Liu; Xia Xu; Zhihai Qin
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

8.  TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease.

Authors:  Rafia S Al-Lamki; Wanhua Lu; Jun Wang; Jun Yang; Timothy J Sargeant; Richard Wells; Chenqu Suo; Penny Wright; Martin Goddard; Qunhua Huang; Amir H Lebastchi; George Tellides; Yingqun Huang; Wang Min; Jordan S Pober; John R Bradley
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

Review 9.  Using advanced noninvasive imaging techniques to probe the links between regional coronary artery endothelial dysfunction and atherosclerosis.

Authors:  Micaela Iantorno; Robert G Weiss
Journal:  Trends Cardiovasc Med       Date:  2013-10-16       Impact factor: 6.677

Review 10.  Tumor Necrosis Factor-α in Heart Failure: an Updated Review.

Authors:  Sarah M Schumacher; Sathyamangla V Naga Prasad
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.